COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 20 of 21 for:    relugolix

Efficacy and Safety of TAK-385 in the Treatment of Endometriosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01458301
Recruitment Status : Completed
First Posted : October 24, 2011
Last Update Posted : February 25, 2014
Information provided by (Responsible Party):